Luigi Lorini

521 total citations
34 papers, 238 citations indexed

About

Luigi Lorini is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Luigi Lorini has authored 34 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Otorhinolaryngology and 14 papers in Surgery. Recurrent topics in Luigi Lorini's work include Head and Neck Cancer Studies (18 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Salivary Gland Tumors Diagnosis and Treatment (6 papers). Luigi Lorini is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Salivary Gland Tumors Diagnosis and Treatment (6 papers). Luigi Lorini collaborates with scholars based in Italy, Spain and United States. Luigi Lorini's co-authors include Paolo Bossi, Cristina Gurizzan, Marco Ravanelli, Chiara Romani, Eliana Bignotti, Urs Müller‐Richter, Michele Tomasoni, Selvam Thavaraj, Alba de Pablo García‐Cuenca and S. Simonetti and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Luigi Lorini

30 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigi Lorini Italy 8 109 79 72 49 39 34 238
N Moeckelmann Germany 4 96 0.9× 110 1.4× 171 2.4× 26 0.5× 33 0.8× 5 228
Ricardo Ribeiro Gama Brazil 8 91 0.8× 62 0.8× 127 1.8× 93 1.9× 57 1.5× 26 297
Laura Sala Italy 5 123 1.1× 118 1.5× 144 2.0× 31 0.6× 22 0.6× 10 223
J. Ton Van France 7 52 0.5× 118 1.5× 89 1.2× 70 1.4× 43 1.1× 7 289
Mark A. M. Broeckaert Netherlands 8 32 0.3× 51 0.6× 42 0.6× 33 0.7× 22 0.6× 14 210
Luca Sala Italy 8 92 0.8× 22 0.3× 18 0.3× 45 0.9× 58 1.5× 24 191
Mateusz Szewczyk Poland 10 96 0.9× 106 1.3× 73 1.0× 64 1.3× 24 0.6× 33 294
M.M. Rietbergen Netherlands 5 94 0.9× 183 2.3× 303 4.2× 73 1.5× 53 1.4× 6 344
Eddy W. Y. Wong Hong Kong 10 45 0.4× 103 1.3× 84 1.2× 46 0.9× 92 2.4× 18 232
Chris McConkey United Kingdom 6 82 0.8× 254 3.2× 116 1.6× 89 1.8× 153 3.9× 11 463

Countries citing papers authored by Luigi Lorini

Since Specialization
Citations

This map shows the geographic impact of Luigi Lorini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Lorini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Lorini more than expected).

Fields of papers citing papers by Luigi Lorini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Lorini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Lorini. The network helps show where Luigi Lorini may publish in the future.

Co-authorship network of co-authors of Luigi Lorini

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Lorini. A scholar is included among the top collaborators of Luigi Lorini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Lorini. Luigi Lorini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrelli, Fausto, Luigi Lorini, Alberto Paderno, et al.. (2025). Treatment of primary tumor in metastatic head and neck Carcinoma: A systematic review and Meta-Analysis. Oral Oncology. 163. 107248–107248. 1 indexed citations
3.
Bossi, Paolo, Andrea Alberti, Cristiana Bergamini, et al.. (2025). Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial. European Journal of Cancer. 220. 115379–115379. 3 indexed citations
5.
Gurizzan, Cristina, Luigi Lorini, Cesare Piazza, et al.. (2025). The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders. Oral Oncology. 168. 107583–107583.
6.
Petrelli, Fausto, Francesca Trevisan, Massimiliano Nardone, et al.. (2025). Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studies. Radiotherapy and Oncology. 210. 111033–111033.
7.
Paderno, Alberto, Fausto Petrelli, Luigi Lorini, et al.. (2024). The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis. Oral Oncology. 153. 106799–106799. 10 indexed citations
8.
Lorini, Luigi, Elisa Salviato, Cesare Piazza, et al.. (2024). Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study). Oral Oncology. 157. 106950–106950. 1 indexed citations
9.
Salvestrini, Viola, Saverio Caini, Pierluigi Bonomo, et al.. (2024). Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis. Frontiers in Oncology. 14. 1395838–1395838. 1 indexed citations
10.
Mattavelli, Davide, Alberto Paderno, Cristina Gurizzan, et al.. (2023). Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy. Cancer Treatment Reviews. 121. 102644–102644. 17 indexed citations
11.
Lorini, Luigi, Mattia Riefolo, Giulia Molinari, et al.. (2023). HER2-targeted therapies for salivary gland cancers. Oral Oncology. 148. 106612–106612. 11 indexed citations
12.
Romani, Chiara, Luigi Lorini, Anna Bozzola, et al.. (2023). Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways. Scientific Reports. 13(1). 1809–1809. 7 indexed citations
13.
Lorini, Luigi, Andrea Alberti, & Paolo Bossi. (2023). Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges. Dermatology Practical & Conceptual. 13(4). e2023251–e2023251. 5 indexed citations
14.
Klinghammer, Konrad, Luigi Lorini, Daan Nevens, et al.. (2022). Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group. Frontiers in Oncology. 12. 730785–730785. 2 indexed citations
15.
Lorini, Luigi, Francesco Perri, Stefania Vecchio, et al.. (2022). Confounding factors in the assessment of oral mucositis in head and neck cancer. Supportive Care in Cancer. 30(10). 8455–8463. 12 indexed citations
16.
Abate, Andrea, Ram Manohar Basnet, Luigi Lorini, et al.. (2022). Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study. Scientific Reports. 12(1). 9951–9951. 6 indexed citations
17.
Lorini, Luigi, Coro Bescós, Selvam Thavaraj, et al.. (2021). Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies. Cancers. 13(15). 3696–3696. 52 indexed citations
18.
Gurizzan, Cristina, Rebecca Pedersini, Manuel Zamparini, et al.. (2021). Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic. Frontiers in Oncology. 11. 707346–707346. 1 indexed citations
19.
Lorini, Luigi, Laura Ardighieri, Anna Bozzola, et al.. (2021). Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma. Oral Oncology. 115. 105213–105213. 41 indexed citations
20.
Gurizzan, Cristina, Luigi Lorini, & Paolo Bossi. (2020). Oral potentially malignant disorders: new insights for future treatment. Current Opinion in Otolaryngology & Head & Neck Surgery. 29(2). 138–142. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026